Forest Sues Sython To Protect Namenda Patent
Forest Laboratories Inc. has launched yet another patent infringement lawsuit in an effort to prevent a generic version of the company's Alzheimer's drug, Namenda, from reaching the market....To view the full article, register now.
Already a subscriber? Click here to view full article